The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer
Abstract
Gene function in cancer can be disrupted either through genetic alterations, which directly mutate or delete genes, or epigenetic alterations, which alter the heritable state of gene expression. The latter events are mediated by formation of transcriptionally repressive chromatin states around gene transcription start sites and an associated gain of methylation in normally unmethylated CpG islands in these regions. The genes affected include over half of the tumor suppressor genes that cause familial cancers when mutated in the germline; the selective advantage for genetic and epigenetic dysfunction in these genes is very similar. The aberrant methylation can begin very early in tumor progression and mediate most of the important pathway abnormalities in cancer including loss of cell cycle control, altered function of transcription factors, altered receptor function, disruption of normal cell-cell and cell-substratum interaction, inactivation of signal transduction pathways, loss of apoptotic signals and genetic instability. The active role of the aberrant methylation in transcriptional silencing of genes is becoming increasingly understood and involves a synergy between the methylation and histone deacetylase (HDAC) activity. This synergy can be mediated directly by HDAC interaction with DNA methylating enzymes and by recruitment through complexes involving methyl-cytosine binding proteins. In the translational arena, the promoter hypermethylation changes hold great promise as DNA tumor markers and their potentially reversible state creates a target for cancer therapeutic strategies involving gene reactivation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143 · cited 1×
“Like DNMT1, these two proteins are essential for mammalian development (60,61), and studies of mouse development suggest that DNMT3a and 3b catalyze, principally, de novo patterns of methylation that arise during this period (60,61).”
BackgroundMethylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
Self-citationNan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440
Cadherin Cell Adhesion Receptors as a Morphogenetic Regulator
Takeichi, M. (1991) · Science · doi:10.1126/science.2006419 · Cited by 3,284
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
Jones, P. L., Veenstra, G. J. C., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., & Wolffe, A. P. (1998) · Nature Genetics · doi:10.1038/561 · Cited by 2,730
CpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J.-P. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,523
Self-citationCancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
Inactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents
Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S. N., Hidalgo, O. F., Vanaclocha, V., Baylin, S. B., & Herman, J. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431901 · Cited by 2,224
Self-citationIncidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
Herman, J. G., Umar, A., Polyak, K., Graff, J. R., Ahuja, N., Issa, J.-P. J., Markowitz, S., Willson, J. K. V., Hamilton, S. R., Kinzler, K. W., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6870 · Cited by 1,887
Self-citationCameron, E. E., Bachman, K. E., Myöhänen, S., Herman, J. G., & Baylin, S. B. (1999) · Nature Genetics · doi:10.1038/5047 · Cited by 1,857
Self-citationMethylation-Induced Repression— Belts, Braces, and Chromatin
Bird, A. P., & Wolffe, A. P. (1999) · Cell · doi:10.1016/s0092-8674(00)81532-9 · Cited by 1,827
Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases
Okano, M., Xie, S., & Li, E. (1998) · Nature Genetics · doi:10.1038/890 · Cited by 1,651
DNA hypermethylation in tumorigenesis: epigenetics joins genetics
Baylin, S. B., & Herman, J. G. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01971-x · Cited by 1,628
Self-citationZhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Kane, M., Loda, M. F., Gaida, G. M., Lipman, J., Mishra, R., Goldman, H., Jessup, J. M., & Kolodner, R. D. (1997) · PubMed · Cited by 1,476
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
Costello, J. F., Frühwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X., Wright, F. A., Feramisco, J. D., Peltomäki, P., Lang, J. C., et al. (2000) · Nature Genetics · doi:10.1038/72785 · Cited by 1,357
Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386761a0 · Cited by 1,240
Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon
Issa, J.-P. J., Ottaviano, Y. L., Celano, P., Hamilton, S. R., Davidson, N. E., & Baylin, S. B. (1994) · Nature Genetics · doi:10.1038/ng0894-536 · Cited by 1,191
Self-citationStott, F. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5001 · Cited by 1,167
DNA methylation in health and disease
Robertson, K. D., & Wolffe, A. P. (2000) · Nature Reviews Genetics · doi:10.1038/35049533 · Cited by 1,057
DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci
Rountree, M. R., Bachman, K. E., & Baylin, S. B. (2000) · Nature Genetics · doi:10.1038/77023 · Cited by 1,052
Self-citationDNA methyltransferase Dnmt1 associates with histone deacetylase activity
Fuks, F., Burgers, W. A., Brehm, A., Hughes-Davies, L., & Kouzarides, T. (2000) · Nature Genetics · doi:10.1038/71750 · Cited by 994
Belinsky, S. A., Nikula, K. J., Palmisano, W. A., Michels, R., Saccomanno, G., Gabrielson, E., Baylin, S. B., & Herman, J. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11891 · Cited by 956
Self-citationRobertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L., & Wolffe, A. P. (2000) · Nature Genetics · doi:10.1038/77124 · Cited by 942
Esteller, M., Sánchez‐Céspedes, M., Rosell, R., Sidransky, D., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 921
Self-citationPredicting lung cancer by detecting aberrant promoter methylation in sputum.
Palmisano, W. A., Divine, K. K., Saccomanno, G., Gilliland, F. D., Baylin, S. B., Herman, J. G., & Belinsky, S. A. (2000) · PubMed · Cited by 891
Self-citationHypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
Cunningham, J. M., Christensen, E. R., Tester, D. J., Kim, C. Y., Roche, P. C., Burgart, L. J., & Thibodeau, S. N. (1998) · PubMed · Cited by 863
Robertson, K. D., Uzvolgyi, E., Liang, G., Talmadge, C., Sumegi, J., Gonzales, F. A., & Jones, P. A. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.11.2291 · Cited by 853
Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation
Wade, P. A., Gegonne, A., Jones, P. L., Ballestar, E., Aubry, F., & Wolffe, A. P. (1999) · Nature Genetics · doi:10.1038/12664 · Cited by 811
DNA methylation and chromatin modification
Ng, H.-H., & Adrian, B. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80024-0 · Cited by 648
Aging and DNA methylation in colorectal mucosa and cancer.
Ahuja, N., Li, Q., MOHAN, A. L., Baylin, S. B., & Issa, J. J. (1998) · PubMed · Cited by 618
Self-citationAnalysis of adenomatous polyposis coli promoter hypermethylation in human cancer.
Esteller, M., Sparks, A. B., Toyota, M., Sánchez‐Céspedes, M., Capellá, G., Peinado, M. A., González, S., Tarafa, G., Sidransky, D., Meltzer, S. J., et al. (2000) · PubMed · Cited by 583
Self-citationEsteller, M., Toyota, M., Sánchez‐Céspedes, M., Capellá, G., Peinado, M. A., Watkins, D. N., Issa, J. J., Sidransky, D., Baylin, S. B., & Herman, J. G. (2000) · PubMed · Cited by 542
Self-citationGene promoter hypermethylation in tumors and serum of head and neck cancer patients.
Sánchez‐Céspedes, M., Esteller, M., Wu, L. J., Nawroz-Danish, H., Yoo, G., Koch, W. M., Jen, J., Herman, J. G., & Sidransky, D. (2000) · PubMed · Cited by 540
Esteller, M., Tórtola, S., Toyota, M., Capellá, G., Peinado, M. A., Baylin, S. B., & Herman, J. G. (2000) · PubMed · Cited by 531
Self-citationDifferential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
Moll, R., Mitze, M., Frixen, U. H., & Birchmeier, W. (1993) · PubMed · Cited by 520
Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.
Wong, I. H. N., Lo, Y. M. D., Zhang, J., Liew, C.-T., Ng, M. H. L., Wong, N., Lai, P. B. S., Lau, W. Y., Hjelm, N. M., & Johnson, P. J. (1999) · PubMed · Cited by 517
Esteller, M., Levine, R., Baylin, S. B., Ellenson, L. H., & Herman, J. G. (1998) · Oncogene · doi:10.1038/sj.onc.1202178 · Cited by 493
Self-citationToyota, M., Ho, C., Ahuja, N., Jair, K. W., Li, Q., Ohe-Toyota, M., Baylin, S. B., & Issa, J. J. (1999) · PubMed · Cited by 464
Self-citationCpG methylation is maintained in human cancer cells lacking DNMT1
Rhee, I., Jair, K.-W., Yen, R.-W. C., Lengauer, C., Herman, J. G., Kinzler, K. W., Vogelstein, B., Baylin, S. B., & Schuebel, K. E. (2000) · Nature · doi:10.1038/35010000 · Cited by 453
Self-citationMethylation profiling of CpG islands in human breast cancer cells
Huang, T. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.3.459 · Cited by 427
p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3
Wales, M. M., Biel, M. A., Deiry, W. E., Nelkin, B. D., Issa, J.-P., Cavenee, W. K., Kuerbitz, S. J., & Baylin, S. B. (1995) · Nature Medicine · doi:10.1038/nm0695-570 · Cited by 421
Self-citationGraff, J. R., Gabrielson, E., Fujii, H., Baylin, S. B., & Herman, J. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2727 · Cited by 393
Self-citationGraff, J. R., Herman, J. G., Myöhänen, S., Baylin, S. B., & Vertino, P. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22322 · Cited by 319
Self-citationSimpkins, S. B., Bocker, T., Swisher, E. M., Mutch, D. G., Gersell, D. J., Kovatich, A. J., Palazzo, J. P., Fishel, R., & Goodfellow, P. J. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.661 · Cited by 319
Nuovo, G. J., Plaia, T. W., Belinsky, S. A., Baylin, S. B., & Herman, J. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12754 · Cited by 314
Self-citationTang, X. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1511 · Cited by 314
Siitonen, S. M., Kononen, J. T., Helin, H. J., Rantala, I. S., Holli, K. A., & Isola, J. J. (1996) · American Journal of Clinical Pathology · doi:10.1093/ajcp/105.4.394 · Cited by 302
Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia.
Myöhänen, S., Baylin, S. B., & Herman, J. G. (1998) · PubMed · Cited by 302
Self-citationDependence of transcriptional repression on CpG methylation density.
Hsieh, C. L. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5487 · Cited by 300
Vertino, P. M., Yen, R.-W. C., Gao, J., & Baylin, S. B. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4555 · Cited by 288
Self-citationBrenner, A. J., Stampfer, M. R., & Aldaz, C. M. (1998) · Oncogene · doi:10.1038/sj.onc.1201919 · Cited by 272
Inactivation of p16 in Human Mammary Epithelial Cells by CpG Island Methylation
Foster, S. A., Wong, D. J., Barrett, M. T., & Galloway, D. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.1793 · Cited by 229
Chiurazzi, P., Grazia Pomponi, M., Pietrobono, R., Bakker, C. E., Neri, G., & Oostra, B. A. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.12.2317 · Cited by 217
Mutagenicity of 5-aza-2′-deoxycytidine is mediated by the mammalian DNA methyltransferase
Jackson-Grusby, L., Laird, P. W., Magge, S. N., Moeller, B. J., & Jaenisch, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4681 · Cited by 208
Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias.
Pietenpol, J. A., Bohlander, S. K., Sato, Y., Papadopoulos, N., Liu, B., Friedman, C., Trask, B. J., Roberts, J. M., Kinzler, K. W., & Rowley, J. D. (1995) · PubMed · Cited by 200
p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas.
Wong, D. J., Barrett, M. T., Stöger, R. J., Emond, M. J., & Reid, B. J. (1997) · PubMed · Cited by 192
Jarrard, D. F., Sarkar, S., Shi, Y., Yeager, T. R., Magrane, G., Kinoshita, H., Nassif, N., Meisner, L. F., Newton, M. A., Waldman, F. M., et al. (1999) · PubMed · Cited by 187
Huschtscha, L. I., Noble, J. R., Neumann, A. A., Moy, E. L., Barry, P. A., Melki, J. R., Clark, S. J., & Reddel, R. R. (1998) · PubMed · Cited by 186
Lübbert, M. (2000) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59696-4_9 · Cited by 169
Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer.
Makos, M., Nelkin, B. D., Lerman, M. I., Latif, F., Zbar, B., & Baylin, S. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1929 · Cited by 163
Self-citationMethylation of the HIC-1 candidate tumor suppressor gene in human breast cancer
Fujii, H., Biel, M. A., Zhou, W., Weitzman, S. A., Baylin, S. B., & Gabrielson, E. W. (1998) · Oncogene · doi:10.1038/sj.onc.1201976 · Cited by 154
Self-citationFerguson, A. T., Vertino, P. M., Spitzner, J. R., Baylin, S. B., Muller, M. T., & Davidson, N. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.32260 · Cited by 146
Self-citationLoughran, Ö., Malliri, A., Owens, D., Gallimore, P. H., Stanley, M., Ozanne, B. W., Frame, M. C., & Parkinson, E. K. (1996) · PubMed · Cited by 143
Cell adhesion and drug resistance in cancer
Croix, B. S., & Kerbel, R. S. (1997) · Current Opinion in Oncology · doi:10.1097/00001622-199711000-00010 · Cited by 138
Aberrant Methylation of Gene Promoters in Cancer--Concepts, Misconcepts, and Promise
Baylin, S. B. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1460 · Cited by 137
Self-citationCarter, M. G. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.3.413 · Cited by 128
Vogt, M., Haggblom, C., Yeargin, J., Christiansen-Weber, T. A., & Haas, M. (1998) · PubMed · Cited by 124
Makos, M., Nelkin, B. D., Reiter, R. E., Gnarra, J. R., Brooks, J. D., Isaacs, W. B., Linehan, W. M., & Baylin, S. B. (1993) · PubMed · Cited by 98
Self-citationGuérardel, C., Deltour, S., Pinte, S., Monté, D., Begue, A., Godwin, A. K., & Leprince, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008690200 · Cited by 74
Momparler, R. L., Côté, S., & Eliopoulos, N. (1997) · Leukemia · doi:10.1038/sj.leu.2400550 · Cited by 70
Cancer metastasis: negative regulation by an invasion-suppressor complex.
Mareel, M., Bracke, M., & Roy, F. M. V. (1995) · PubMed · Cited by 60
Cited by
Gene Silencing in Cancer in Association with Promoter Hypermethylation
Herman, J. G., & Baylin, S. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023075 · Cited by 3,422
Self-citationMulti-omics approaches to disease
Hasin, Y., Seldin, M., & Lusis, A. (2017) · Genome Biology · doi:10.1186/s13059-017-1215-1 · Cited by 2,953
Christman, J. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205699 · Cited by 1,525
CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future
Esteller, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205600 · Cited by 1,233
Causal Relationship between the Loss of RUNX3 Expression and Gastric Cancer
Li, Q.-L., Ito, K., Sakakura, C., Fukamachi, H., Inoue, K.-I., Chi, X.-Z., Lee, K.-Y., Nomura, S., Lee, C.-W., Han, S.-B., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00690-6 · Cited by 1,028
Metadata
- Authors
- Baylin, S. B.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-04-01
- Volume
- 10
- Issue
- 7
- Pages
- 687-692
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2137915568
- Cited by
- 929
- References
- 72
- FWCI
- 21.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.